Mpox Info & Updates

Información acerca de la viruela del mono… [Spanish]

Diagnosis & Treatment|Testing|Vaccination

Monkeypox (now known as MPOX) is circulating in our community, and we want to make sure you have the info you need about what’s going on.

Symptoms often start with flu-like symptoms, including fever, headache, and fatigue, but not everyone has these symptoms. 1 to 3 days later, people may get a rash or “blisters” on the face, arms, legs, hands, feet, and genital and anal areas – the genital/anal rash appear to be very common during this outbreak. It usually takes around 5 to 14 days after any exposure for symptoms to appear (the “incubation period”). Find more answers to Frequently Asked Questions.

Diagnosis & Treatment

Magnet is available for diagnosis and treatment for people that develop rashes around their genitals and/or anal area, and/or on face, hands/feet, and other parts of the body that may be caused by MPOX or another infection. Call us at 415-581-1600 to schedule a visit.

Testing

Testing for MPOX involves taking a swab of the rash to see if it might be caused by MPOX or a different infection. Only those experiencing rash or blister-like symptoms may receive testing at this time, which involves taking a swab of the rash. Call us at 415-581-1600 to schedule a visit.

Vaccination

MPOX vaccinations are now available to:

Cis gay, bisexual, and other men who have sex with men
All transgender and nonbinary individuals (who have sex with cis men or trans folks assigned male at birth)
People in the sex trade of any sexual orientation or gender identity
People who have had close contact in the last 6 months with someone with suspected or confirmed MPOX
People who had close contact with others at a venue or event in a social group in the past 6 months where a suspected or confirmed MPOX case was identified
People who anticipate experiencing any of the above
People who are living with HIV
People who are taking or are eligible to take PrEP
Lab workers who routinely perform MPOX virus testing
Clinicians who are likely to collect lab samples from people with MPOX
Clinicians who have had a high-risk occupational exposure (e.g., examined MPOX lesions or collected MPOX specimens without using recommend personal protective equipment)

We are providing the JYNNEOS vaccine. The JYNNEOS vaccine is a two-dose vaccine and we recommend that you receive both doses at least 28 days apart for maximal protection. Although vaccine supply is still somewhat limited, most people who need access to the JYNNEOS vaccine should be able to receive dose #1 and/or dose #2. Please call us at 415-581-1600 if you’d like to receive the vaccine.

Second doses of vaccine

We are providing the second dose of the JYNNEOS vaccine to people who are beyond 28 days from receiving their first dose.

Intradermal dosing

In order to maximize the availability of the JYNNEOS vaccine to community members, the FDA has provided authorization for an intradermal vaccination that we are now required to follow. Instead of administering the JYNNEOS vaccine as a subcutaneous injection, the JYNNEOS vaccine is now administered as an intradermal injection. This alternative way to administer the vaccine allows as many as five times the number of doses to come from a single vial of JYNNEOS. The intradermal administration works as well as the subcutaneous administration despite the lower dose. People under age 18 and people with a history of keloid scarring will continue to receive a subcutaneous dose. For more information, see our FAQs about intradermal dosing.

Last updated on January 13, 2023. SFAF will continue to update this page as additional information becomes available.

Mpox Info & Updates